The CYP2B subfamily

Issues in Toxicology

Volumn , Issue , 2008, Pages 178-199

  Corcos, Laurent ^a   Berthou, François ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897510886     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: 10.1039/9781847558428-00178     Document Type: Article

References (91)

1. T. Omura and R. Sato, J. Biol. Chem., 1962, 237, 1375-1376.
2. C. Ioannides and D.V. Parke, Biochem. Pharmacol., 1987, 36, 4197-4207.
3. M. Atchison and M. Adesnik, J. Biol. Chem., 1983, 258, 11285-11295.
4. M. Atchison and M. Adesnik, Proc. Natl. Acad. Sci. USA, 1986, 83, 2300-2304.
5. B.H. Kim and A.J. Fulco, Biochem. Biophys. Res. Commun., 1983, 116, 843-850.
6. G. Bronzetti and R. Del Carratore, Basic Life Sci., 1986, 39, 343-348.
7. J.S. He and A.J. Fulco, J. Biol. Chem., 1991, 266, 7864-7869.
8. E. Trottier, A. Belzil, C. Stoltz and A. Anderson, Gene, 1995, 158, 263-268.
9. P. Honkakoski and M. Negishi, J. Biol. Chem., 1997, 272, 14943-14949.
10. P.M. Shaw, M. Adesnik, M.C. Weiss and L. Corcos, Mol. Pharmacol., 1993, 44, 775-783.
11. P. Honkakoski, I. Zelko, T. Sueyoshi and M. Negishi, Mol. Cell Biol., 1998, 18, 5652-5658.
12. S.A. Kliewer, J.T. Moore, L. Wade, J.L. Staudinger, M.A. Watson, S.A. Jones, D.D. McKee, B.B. Oliver, T.M. Willson, R.H. Zetterstrom, T. Perlmann and J.M. Lehmann, Cell, 1998, 92, 73-82.
13. E.E. Scott, Y.A. He, M.R. Wester, M.A. White, C.C. Chin, J.R. Halpert, E.F. Johnson and C.D. Stout, Proc. Natl. Acad. Sci. USA, 2003, 100, 13196-13201.
14. L. Chen and D.J. Waxman, Cancer Res., 1995, 55, 581-589.
15. Y. Jounaidi and D.J. Waxman, Cancer Res., 2000, 60, 3761-3769.
16. M. Tychopoulos, L. Corcos, P. Genne, P. Beaune and I. de Waziers, Cancer Gene Ther., 2005, 12, 497-508.
17. M. Desrochers, M. Christou, C. Jefcoate, A. Belzil, A. Anderson, Biochem. Pharmacol., 1996, Oct 25;52(8):1311-1319.
18. J.S. Miles, A.W. McLaren and C.R. Wolf, Nucleic Acids Res., 1989, 17, 8241-8255.
19. K.M. Kedzie, C.A. Balfour, G.Y. Escobar, S.W. Grimm, Y.A. He, D.J. Pepperl, J.W. Regan, J.C. Stevens and J.R. Halpert, J. Biol. Chem., 1991, 266, 22515-22521.
20. R.W. Nims and R.A. Lubet, J. Toxicol. Environ. Health, 1995, 46, 271-292.
21. T.K. Chang, C.L. Crespi and D.J. Waxman, Methods Mol. Biol., 2006, 320, 97-102.
22. M. Turpeinen, H. Raunio and O. Pelkonen, Curr. Drug Metab., 2006, 7, 705-714.
23. E. Hodgson, R.L. and Rose (2006). The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals. Pharmacol Ther., in press.
24. R.L. Walsky, A.V. Astuccio and R.S. Obach, J. Clin. Pharmacol., 2006, 46, 1426-1438.
25. C.M. Giachelli and C.J. Omiecinski, J. Biol. Chem., 1986, 261, 1359-1363.
26. C.J. Omiecinski, C. Hassett and P. Costa, Mol. Pharmacol., 1990, 38, 462-470.
27. M. Mimura, T. Baba, H. Yamazaki, S. Ohmori, Y. Inui, F.J. Gonzalez, F.P. Guengerich and T. Shimada, Drug Metab. Dispos., 1993, 21, 1048-1056.
28. J. Hukkanen, O. Pelkonen, J. Hakkola and H. Raunio, Crit. Rev. Toxicol., 2002, 32, 391-411.
29. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui and F.P. Guengerich, J. Pharmacol. Exp. Ther., 1994, 270, 414-423.
30. V. Lamba, J. Lamba, K. Yasuda, S. Strom, J. Davila, M. L. Hancock, J.D. Fackenthal, P. K. Rogan, B. Ring, S. A. Wrighton, & E. G. Schuetz, (2003).
31. I.H. Hanna, J.R. Reed, F.P. Guengerich and P.F. Hollenberg, Arch. Biochem. Biophys., 2000, 376, 206-216.
32. N. Harada and M. Negishi, Proc. Natl. Acad. Sci. USA, 1985, 82, 2024-2028.
33. M. Noshiro and M. Negishi, J. Biol. Chem., 1986, 261, 15923-15927.
34. H.W. Davey, S.H. Park, D.R. Grattan, M.J. McLachlan and D.J. Waxman, J. Biol. Chem., 1999, 274, 35331-35336.
35. B.H. Shapiro, N.A. Pampori, D.P. Lapenson and D.J. Waxman, Arch. Biochem. Biophys., 1994, 312, 234-239.
36. K. Jarukamjorn, T. Sakuma and N. Nemoto, Biochem. Pharmacol., 2002, 63, 2037-2041.
37. Y. Yamazoe, N. Murayama, M. Shimada, K. Yamauchi and R. Kato, Arch. Biochem. Biophys., 1989, 268, 567-575.
38. B.S. Donahue and E.T. Morgan, Drug Metab. Dispos., 1990, 18, 519-526.
39. Z. Abdel-Razzak, L. Corcos, A. Fautrel and A. Guillouzo, FEBS Lett., 1995, 366, 159-164.
40. O. Khatsenko and Y. Kikkawa, J. Pharmacol. Exp. Ther., 1997, 280, 1463-1470.
41. T. Li-Masters and E.T. Morgan, Drug Metab. Dispos., 2001, 29, 252-257.
42. P.J. Van Ess, S. Poloyac, M.P. Mattson and R.A. Blouin, Pharm. Res., 2002, 19, 708-712.
43. Z. Abdel-Razzak, P. Loyer, A. Fautrel, J.C. Gautier, L. Corcos, B. Turlin, P. Beaune and A. Guillouzo, Mol. Pharmacol., 1993, 44, 707-715.
44. E.L. LeCluyse, Eur. J. Pharm. Sci., 2001, 13, 343-368.
45. C. Lerche, A. Fautrel, P.M. Shaw, D. Glaise, F. Ballet, A. Guillouzo and L. Corcos, Eur. J. Biochem., 1997, 244, 98-106.
46. J. B. Ferrini, L. Pichard, J. Domergue and P. Maurel, Chem. Biol. Interact., 1997, 107, 31-45.
47. G. Tuschl and S.O. Mueller, Toxicology, 2006, 218, 205-215.
48. J.Z. Tong, P. De Lagausie, V. Furlan, T. Cresteil, O. Bernard and F. Alvarez, Exp. Cell Res., 1992, 200, 326-332.
49. E.S. Tzanakakis, C.C. Hsiao, T. Matsushita, R.P. Remmel and W.S. Hu, Cell Transplant, 2001, 10, 329-342.
50. L. Corcos and M.C. Weiss, FEBS Lett., 1988, 233, 37-40.
51. J. Doehmer, S. Dogra, T. Friedberg, S. Monier, M. Adesnik, H. Glatt and F. Oesch, Proc. Natl. Acad. Sci. USA, 1988, 85, 5769-5773.
52. J.L. Ferrero and K. Brendel, Adv. Pharmacol., 1997, 43, 131-169.
53. X. Cui, A. Thomas, Y. Han, J. Palamanda, D. Montgomery, R.E. White, R.A. Morrison and K.C. Cheng, J. Pharmacol. Toxicol. Methods, 2005, 52, 234-243.
54. Y. Park, H. Li and B. Kemper, J. Biol. Chem., 1996, 271, 23725-23728.
55. M. Damon, A. Fautrel, A. Guillouzo and L. Corcos, Biochem. J., 1996, 317(Pt 2), 481-486.
56. T.J. Dunn, A.J. Koleske, R. Lindahl and H.C. Pitot, J. Biol. Chem., 1989, 264, 13057-13065.
57. K.M. Sommer, R. Ramsden, J. Sidhu, P. Costa and C.J. Omiecinski, Pharmacogenetics, 1996, 6, 369-374.
58. P.V. Luc, M. Adesnik, S. Ganguly and P.M. Shaw, Biochem. Pharmacol., 1996, 51, 345-356.
59. P. Honkakoski, R. Moore, K.A. Washburn and M. Negishi, Mol. Pharmacol., 1998, 53, 597-601.
60. N. Marc, M. Galisteo, D. Lagadic-Gossmann, A. Fautrel, F. Joannard, A. Guillouzo and L. Corcos, Eur. J. Biochem., 2000, 267, 963-970.
61. T. Kawamoto, T. Sueyoshi, I. Zelko, R. Moore, K. Washburn and M. Negishi, Mol. Cell Biol., 1999, 19, 6318-6322.
62. J.S. Miles, A.W. McLaren, F.J. Gonzalez and C.R. Wolf, Nucleic Acids Res., 1990, 18, 189.
63. C. Rodriguez-Antona and M. Ingelman-Sundberg, Oncogene, 2006, 25, 1679-1691.
64. K. Nagata and Y. Yamazoe, Drug Metab. Pharmacokinet, 2002, 17, 167-189.
65. T. Lang, K. Klein, J. Fischer, A.K. Nussler, P. Neuhaus, U. Hofmann, M. Eichelbaum, M. Schwab and U.M. Zanger, Pharmacogenetics, 2001, 11, 399-415.
66. N. Ariyoshi, M. Miyazaki, K. Toide, Y. Sawamura and T. Kamataki, Biochem. Biophys. Res. Commun., 2001, 281, 1256-1260.
67. K. Klein, T. Lang, T. Saussele, E. Barbosa-Sicard, W.H. Schunck, M. Eichelbaum, M. Schwab and U.M. Zanger, Pharmacogenet Genomics, 2005, 15, 861-873.
68. J. Wang, A. Sonnerborg, A. Rane, F. Josephson, S. Lundgren, L. Stahle and M. Ingelman-Sundberg, Pharmaco.genet. Genomics, 2006, 16, 191-198.
69. D. Nolan, E. Phillips and S. Mallal, Clin. Infect. Dis., 2006, 42, 408-410.
70. M. Spatzenegger, Q. Wang, Y.Q. He, M.R. Wester, E.F. Johnson and J.R. Halpert, Mol. Pharmacol., 2001, 59, 475-484.
71. M.X. Wei, T. Tamiya, M. Chase, E.J. Boviatsis, T.K. Chang, N.W. Kowall, F.H. Hochberg, D.J. Waxman, X.O. Breakefield and E.A. Chiocca, Hum. Gene Ther., 1994, 5, 969-978.
72. L. Chen and D.J. Waxman, Curr. Pharm. Des., 2002, 8, 1405-1416.
73. P. Roy and D.J. Waxman, Toxicol. In vitro, 2006, 20, 176-186.
74. L. Chen, L.J. Yu and D.J. Waxman, Cancer Res., 1997, 57, 4830-4837.
75. H. Li and T.L. Poulos, Curr. Top. Med. Chem., 2004, 4, 1789-1802.
76. Y. Zhao and J.R. Halpert, Biochim. Biophys. Acta, 2007, 1770, 402-412.
77. P.A. Williams, J. Cosme, V. Sridhar, E.F. Johnson and D.E. McRee, J. Inorg. Biochem., 2000, 81, 183-190.
78. G.A. Schoch, J.K. Yano, M.R. Wester, K.J. Griffin, C.D. Stout and E.F. Johnson, J. Biol. Chem., 2004, 279, 9497-9503.
79. P.A. Williams, J. Cosme, A. Ward, H.C. Angove, D. Matak Vinkovic and H. Jhoti, Nature, 2003, 424, 464-468.
80. M.R. Wester, J.K. Yano, G.A. Schoch, C. Yang, K.J. Griffin, C.D. Stout and E.F. Johnson, The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-Å resolution, J. Biol. Chem., 2004, 279, 35630-35637.
81. B.K. Muralidhara, S. Negi, C.C. Chin, W. Braun and J.R. Halpert, J. Biol. Chem., 2006, 281, 8051-8061.
82. Y. Zhao, M.A. White, B.K. Muralidhara, L. Sun, J.R. Halpert and C.D. Stout, J. Biol. Chem., 2006, 281, 5973-5981.
83. J.K. Yano, M.R. Wester, G.A. Schoch, K.J. Griffin, C.D. Stout and E.F. Johnson, J. Biol. Chem., 2004, 279, 38091-38094.
84. P.A. Williams, J. Cosme, D.M. Vinkovic, A. Ward, H.C. Angove, P.J. Day, C. Vonrhein, I.J. Tickle and H. Jhoti, Science, 2004, 305, 683-686.
85. M. Ekroos and T. Sjogren, Proc. Natl. Acad. Sci. USA, 2006, 103, 13682-13687.
86. P. Rowland, F.E. Blaney, M.G. Smyth, J.J. Jones, V.R. Leydon, A.K. Oxbrow, C.J. Lewis, M.G. Tennant, S. Modi, D.S. Eggleston, R.J. Chenery and A.M. Bridges, Crystal structure of human cytochrome P450 2D6, J. Biol. Chem., 2006, 281, 7614-7622.
87. J.K. Yano, M.H. Hsu, K.J. Griffin, C.D. Stout and E.F. Johnson, Nat. Struct. Mol. Biol., 2005, 12, 822-823.
88. S.E. Graham and J.A. Peterson, Arch. Biochem. Biophys., 1999, 369, 24-29.
89. F.P. Guengerich, Proc. Natl. Acad. Sci. USA, 2006, 103, 13565-13566.
90. T.L. Poulos, B.C. Finzel, I.C. Gunsalus, G.C. Wagner and J. Kraut, J. Biol. Chem., 1985, 260, 16122-16130.
91. J. Zhao, A. Das, X. Zhang, G.C. Schatz, S.G. Sligar and R.P. Van Duyne, Resonance surface plasmon spectroscopy: low molecular weight substrate binding to cytochrome p450, J. Am. Chem. Soc., 2006a, 128, 11004-11005.